SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-160177
Filing Date
2020-06-04
Accepted
2020-06-04 08:40:33
Documents
3
Effectiveness Date
2020-06-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A d938092ddefa14a.htm DEFA14A 38590
2 GRAPHIC g938092tx1.jpg GRAPHIC 8851
3 GRAPHIC g938092tx5.jpg GRAPHIC 3338
  Complete submission text file 0001193125-20-160177.txt   56907
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-31141 | Film No.: 20941957
SIC: 2834 Pharmaceutical Preparations